| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |